Page last updated: 2024-08-25

1-ethyl-2-benzimidazolinone and bumetanide

1-ethyl-2-benzimidazolinone has been researched along with bumetanide in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (66.67)18.2507
2000's1 (33.33)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bridges, RJ; Devor, DC; Frizzell, RA; Singh, AK1
Bridges, RJ; DeLuca, A; Devor, DC; Frizzell, RA; Lambert, LC; Singh, AK1
Ishikawa, T; Ito, Y; Kondo, M; Kume, H; Nakayama, S; Sato, S; Shimokata, K; Son, M1

Other Studies

3 other study(ies) available for 1-ethyl-2-benzimidazolinone and bumetanide

ArticleYear
Modulation of Cl- secretion by benzimidazolones. I. Direct activation of a Ca(2+)-dependent K+ channel.
    The American journal of physiology, 1996, Volume: 271, Issue:5 Pt 1

    Topics: Amiloride; Animals; Benzimidazoles; Bumetanide; Calcium; Cell Line; Cells, Cultured; Charybdotoxin; Chlorides; Colforsin; Colon; Epithelium; Intestinal Mucosa; Kinetics; Mice; Potassium Channels; Rats; Rubidium; Trachea

1996
Bicarbonate and chloride secretion in Calu-3 human airway epithelial cells.
    The Journal of general physiology, 1999, Volume: 113, Issue:5

    Topics: Benzimidazoles; Bicarbonates; Bumetanide; Calcium Channel Agonists; Cell Line; Chlorides; Colforsin; Diuretics; Electrophysiology; Epithelial Cells; Humans; Ion Channel Gating; Patch-Clamp Techniques; Potassium Channel Blockers; Potassium Channels; Stilbenes

1999
ATP release triggered by activation of the Ca2+-activated K+ channel in human airway Calu-3 cells.
    American journal of respiratory cell and molecular biology, 2004, Volume: 30, Issue:3

    Topics: Adenosine Diphosphate; Adenosine Triphosphate; Benzimidazoles; Bumetanide; Calcium; Cell Size; Charybdotoxin; Chlorzoxazone; Colforsin; Cystic Fibrosis Transmembrane Conductance Regulator; Cytosol; Epithelial Cells; Glyburide; Humans; Ionomycin; Isoproterenol; Luciferases; Lung; Potassium Channels, Calcium-Activated; Potassium Chloride; Purinergic P2 Receptor Antagonists; Receptors, Purinergic P2Y1

2004